Pages that link to "Q42672170"
Jump to navigation
Jump to search
The following pages link to Mendelian randomization: nature's randomized trial in the post-genome era. (Q42672170):
Displaying 35 items.
- Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses (Q30688472) (← links)
- Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics (Q33992299) (← links)
- Using instrumental variables to estimate a Cox's proportional hazards regression subject to additive confounding (Q34668329) (← links)
- Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study (Q35136767) (← links)
- Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. (Q35832781) (← links)
- Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics (Q35895453) (← links)
- A Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research Literature (Q36176050) (← links)
- Lipoprotein(a) and cardiovascular disease in diabetic patients (Q36369444) (← links)
- Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial (Q36477848) (← links)
- State- and trait-dependent associations of vitamin-D with brain function during aging (Q36638989) (← links)
- Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps (Q36740734) (← links)
- Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis (Q36930213) (← links)
- Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention (Q37148908) (← links)
- Genetics of Dyslipidemia and Ischemic Heart Disease (Q38692446) (← links)
- Insight into rheumatological cause and effect through the use of Mendelian randomization (Q38895577) (← links)
- Using multiple genetic variants as instrumental variables for modifiable risk factors (Q41931960) (← links)
- Genomic medicine for improved prediction and primordial prevention of cardiovascular disease (Q42905154) (← links)
- Use of allele scores as instrumental variables for Mendelian randomization (Q42970966) (← links)
- Comorbidity: preventable premature morbidity and mortality due to skin disease (Q43721222) (← links)
- Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study (Q44778916) (← links)
- Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib (Q46562930) (← links)
- Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. (Q47410087) (← links)
- HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics (Q47657807) (← links)
- How to use Mendelian randomization to anticipate the results of randomized trials (Q50094258) (← links)
- Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study (Q51607498) (← links)
- Blood HER2 and Uromodulin as Causal Mediators of CKD. (Q51743726) (← links)
- Large-Scale Genomic Biobanks and Cardiovascular Disease. (Q52665484) (← links)
- Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis (Q91651602) (← links)
- Improving the odds of drug development success through human genomics: modelling study (Q91891350) (← links)
- Epidemiology, genetic epidemiology and Mendelian randomisation: more need than ever to attend to detail (Q92328834) (← links)
- A robust and efficient method for Mendelian randomization with hundreds of genetic variants (Q92739890) (← links)
- Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile (Q93017355) (← links)
- Association of Cortisol Levels With Neuropsychiatric Functions: A Mendelian Randomization Analysis (Q93047467) (← links)
- Polygenic modelling of treatment effect heterogeneity (Q98305099) (← links)
- Evaluation of the causal effects of blood lipid levels on gout with summary level GWAS data: two-sample Mendelian randomization and mediation analysis (Q100990209) (← links)